GlobeNewswire by notified

Abel Noser Solutions Teams Up With Neovest to Provide Reporting Options for Traders, Managers and Brokers

Share

Clients of both firms will benefit from a cost-effective reporting package that monitors best execution details and provides actionable feedback on liquidity analysis, trade measurement and regulatory reporting.

New York, NY, March 29, 2022 (GLOBE NEWSWIRE) -- Abel Noser Solutions announced today that Abel Noser has teamed up with Neovest to create a specialized analytics reporting offering for clients and clients’ affiliates. The service provides traders, portfolio managers and brokers comprehensive summaries, enhanced analytics reports to aid best execution review and analysis, fill-level review including broker/venue analysis, and commission comparisons along with execution consulting. Neovest, a global, multi-asset order and execution management system, will now offer its clients access to Abel Noser’s integrated analytics suite of reports through a cloud-based dashboard.

Commenting on the announcement, Peter Weiler, Co-CEO of Abel Noser said, “We are thrilled to work with Neovest to provide this specialized reporting solution that monitors best execution quality by broker for the buy-side as well as sales trader summaries for brokers. Our partnership provides robust analytics from numerous perspectives, so clients can remain compliant and competitive in the everchanging investment landscape.”

“As clients demand a seamless workflow around regulatory compliance and reporting, I am happy to welcome Abel Noser into our partner program. Neovest is aggressively investing in its product and the tools that Abel Noser offers further strengthen the solutions Neovest offers clients. This partnership helps complete the trade lifecycle by complementing Neovest’s robust execution tools with Abel Noser’s industry-leading TCA and compliance products,” said Jimmi Shah, CEO of Neovest.

“This exciting collaboration will provide a multi-faceted analytics solution with valuable attributes to both the buy-side and sell-side,” added Brett Macleod, Managing Director at Abel Noser Solutions.  “From manager performance summaries and trade-level performance metrics to next-gen analytics that utilize client benchmarks and our $15 trillion trade data universe, we feel this offering will allow Neovest to leverage our alpha capturing and compliance applications for a value-added service provision.”

About Abel Noser Solutions
Abel Noser Solutions has long been respected as a leader in the campaign to lower the costs associated with trading. With over 500 clients worldwide, Abel Noser Solutions offers software products along with consultative and bespoke services in the areas of trade analytics, compliance, and trade surveillance. The firm continues to hold its place as the leading innovator in TCA, compliance software, and service solutions. Rated 2021 Best-In-Class Global Multi-Asset TCA Provider by Aite Group. Learn more at www.abelnoser.com.

About Neovest
Neovest is a global, multi-asset, broker-neutral order and execution management platform with 600+ clients, 4,000+ users and connectivity to 350+ global brokers.  As an independently operated technology company, Neovest provides a fully integrated front-to-back solution leveraged by the industry's most advanced buy-side and sell-side clients.
www.neovest.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results28.3.2024 21:05:00 CET | Press release

SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis in their own lab, today announced financial results for the fourth quarter and year ended December 31, 2023. Results highlight strong BioXp® kit sales, expanding gross margin and reduced operating expense. In discussing the results, Todd R. Nelson Ph.D., Founder and CEO of Telesis Bio said, “I’m pleased with our operating execution in a challenging macro environment during 2023. Our company experienced record BioXp kits sales and expanding gross margin against the backdrop of significant cost cutting initiatives undertaken to align our operating structure with our strategic vision for growth. We believe that our rapid and flexible mRNA synthesis kits are game-changing and unlock tremendous value by providing customers control over their screening and d

Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings28.3.2024 21:01:00 CET | Press release

Publication of annual report for financial year 2023Annual Shareholders’ Meeting resolutions include approval of revised Remuneration Policy and (re)appointment of Board membersExtraordinary Shareholders’ Meeting resolutions include approval of renewal of authorized capital and issuance of Gilead Subsequent Warrant B Mechelen, Belgium; 28 March 2024, 21.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today publishes its annual report for the financial year 2023 and announces its Annual and Extraordinary Shareholders’ Meetings (AGM and EGM) to be held sequentially on Tuesday, 30 April 2024 at 2:00 pm (CET) and 3:00 pm (CET), respectively, at the registered office of the Company. The annual report for the financial year 2023, including a review of figures and performance, is available online at https://www.glpg.com/financial-reports and can also be downloaded as PDF. Our annual 2023 Form 20-F filing with the SEC is available at www.sec.gov/edgar. Galapagos has the

McWhorter Foundation Preparing Legal Battle Against J.P. Morgan Over IPO Discrimination and LBO Biases28.3.2024 19:28:47 CET | Press release

PALM BEACH, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- McWhorter Foundation is poised to launch a groundbreaking legal battle against financial giant J.P. Morgan. With a focus on challenging discriminatory practices in leveraged buyouts (LBOs) and initial public offerings (IPOs), The McWhorter Foundation aims to break down barriers and advocate for equal access to capital markets. Exposing Inequities in IPOs: Recent analyses have highlighted disparities in IPO access, with minority-owned businesses facing systemic hurdles in accessing public markets. McWhorter's legal challenge will illuminate these inequities, compelling J.P. Morgan to address its role in perpetuating barriers to entry for underrepresented entrepreneurs. Leveraging Data for Change: Backed by comprehensive data and extensive research, McWhorter's legal team will present compelling evidence of discrimination in J.P. Morgan's IPO practices. By highlighting patterns of exclusion and unequal treatment, McWhorter Foundation s

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC28.3.2024 19:00:00 CET | Press release

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – March 28, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on March 27, 2024, from Atlas Special Opportunities, LLC indicating that as of March 19, 2024, it held 0 (zero) shares of the then outstanding 5,753,951,723 shares, and therefore crossed below the threshold (3%) by virtue of the sale of voting securities. See Annex 1. About Oxurion Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com. Important information about forward-looking statements Certain statements in this press rele

C.K. McWhorter: Running to a Solution Of Equality and Sustainability28.3.2024 18:48:29 CET | Press release

MIAMI, March 28, 2024 (GLOBE NEWSWIRE) -- In a groundbreaking endeavor, C.K. McWhorter, renowned for his pioneering spirit in luxury and finance, is embarking on a transformative journey to reshape the narrative of desirability. By harnessing the allure of luxury, McWhorter aims to catalyze a paradigm shift towards equality and sustainability, ensuring that these principles become the most coveted and revered ideals worldwide. With a profound understanding of the power of influence, McWhorter recognizes that luxury sets the standard for aspiration and desire. Leveraging this influence, he seeks to redefine what it means to truly desire and value, shifting the focus from just material possessions to ethical principles that benefit humanity and the planet. "Luxury has long been synonymous with opulence and exclusivity, but it's time for us to redefine its meaning," says McWhorter. "True luxury is in equality and sustainability – in knowing that our desires are aligned with values that up

HiddenA line styled icon from Orion Icon Library.Eye